Font Size: a A A

The Studies Of Clinical Features And OROS-MPH Effects Of Subtypes Of Attention Deficit Hyperactivity Disorder On Children

Posted on:2010-06-12Degree:MasterType:Thesis
Country:ChinaCandidate:Y Z ChenFull Text:PDF
GTID:2144360275454113Subject:Academy of Pediatrics
Abstract/Summary:PDF Full Text Request
Objective:1.To analyze the features of various subtypes of attention deficit hyperactivity disorder(ADHD) in children;2.To study the effects of methylphenidate extended-release tablets (OROS-MPH) on various Subtypes of ADHD;3.To evaluate the effects of EEG biofeedback on ADHD.Methods:1.Clinical features of Subtypes of ADHD in Children:Sex composition,age of onset, risk factors,comorbidities,intelligence quotient and behavioral problems were analyzed in 175 children with ADHD(82 ADHD-I,24 ADHD-HI and 69 ADHD-C) who met the 4th edition of Diagnostic Statistical Manual of Mental disorder criteria(DSM-Ⅳ).2.Effects of OROS-MPH on various Subtypes of ADHD:92 children with ADHD(35 ADHD-I,19 ADHD-HI and 38 ADHD-C) who met the DSM-Ⅳdiagnostic criteria were given OROS-MPH for 6 weeks.The efficacy of OROS-MPH was evaluated according to IOWA Conners Parents Rating Scale and Conners Parents Rating Scale every two weeks.3.Effects of EEG Biofeedback on Children with ADHD:60 children with ADHD who met the DSM-Ⅳdiagnostic criteria were randomly assigned to Electroencephalogram(EEG) biofeedback group(30 cases) and OROS-MPH group (30 cases).Effects of EEG biofeedback and OROS-MPH were compared before and after the interventions according to IOWA Conners rating scale and integrated visual and auditory continuous performance test(IVA-CPT).All the patients were followed-up for two months after the interventions.Results:1.Clinical features of Subtypes of ADHD in Children:There were no significantly differences on sex composition among the three subtypes(P>0.05);Both the age of onset and age at diagnosis in the group with ADHD-HI were the youngest,then the group with ADHD-C and the group with ADHD-I in turn;The rates of birth abnormality in the ADHD-I and the ADHD-C were higher than those in the ADHD-HI,the rates of improper parent's education in the ADHD-HI and the ADHD-C were higher than those in the ADHD-I;There were no significant differences for performance intelligence quotient(PIQ),verbal intelligence quotient(VIQ) and full intelligence quotient(FIQ) among the three subtype(P>0.05).However,the incidences of imbalance between VIQ and PIQ in ADHD-I were the highest.For the ADHD-C and the ADHD-HI,the incidences of comorbidities with oppositional defiant disorder(ODD) and tic disorder(TD) were higher than those in the ADHD-I.Both the ADHD-I and the ADHD-C had higher incidence of comorbidity with learning disorder(LD) compared to the ADHD-HI; Implusive/hyperactive,conduct problem and hyperactivity index in the ADHD-C and the ADHD-HI were more than those in the ADHD-I based on Conners Parent Rating Scales,but the learning problems of ADHD-I were the worst among the three subtypes.2.Effects of OROS-MPH on various Subtypes of ADHD:The scores of I/O,O/D and the total of IOWA Conners Rating Scale after the OROS-MPH therapy were lower than those before the therapy in the three groups(P<0.05).The difference values of the scores of IOWA Conners Rating Scale between before and after the interventions in the ADHD-C group and the ADHD-HI group were higher than those in the ADHD-I group,but no significant differences between the ADHD-HI group and the ADHD-C group.The scores of Conners Rating Scale reduced significantly after the therapy in the three groups(P<0.05).The difference values of the scores between before and after the interventions in the ADHD-C group and the ADHD-HI group were higher than those in the ADHD-I group on conduct problem,actuation/hyperactivity and hyperactivity index,but no significantly difference between the ADHD-HI group and the ADHD-C group.The difference values of the scores on learning problem between before and after interventions in the ADHD-I group were higher than those in the ADHD-C group and the ADHD-HI group.3.Effects of EEG Biofeedback on Children with ADHD:There were significant differences before and after the EEG biofeedback training or OROS-MPH therapy for the scores of IOWA Conners Rating Scale and the indexes of IVA-CPT such as the full scale response control quotient and the full scale attention quotient(P<0.05).But the indexes and the scores in the OROS-MPH group improved better than those in the EEG biofeedback group(P<0.05).The scores of IOWA Conners Rating Scale rebounded when the OROS-MPH was discontinued in OROS-MPH group,however,EEG biofeedback group showed a persistent improvement.Conclusion:1.There are significant differences on comorbidities,intelligence quotient and behavioral problems among the three subtypes of ADHD.The incidences of comorbidities with ODD,TD and disruptive behavior problems in the ADHD-C group and the ADHD-HI group were higher than the ADHD-I group.But there are higher incidences of learning problems and imbalance between VIQ and PIQ in the ADHD-I group.It is suggested that different pathogenesises may play a role in various subtypes of ADHD.2.OROS-MPH is effective and safe for children with ADHD.There are significant differences of OROS-MPH's efficacies among subtypes of ADHD in children.Generally,OROS-MPH shows better effects on both the ADHD-C group and the ADHD-HI group than those on the ADHD-I group.There are significant improvements on disruptive behavior problems both in the ADHD-C group and the ADHD-HI group,and on learning problems in the ADHD-I group.3.EEG biofeedback training is an effective treatment for children with ADHD.But the short term effects of EEG biofeedback is inferior to OROS-MPH.EEG biofeedback training shows slower but more stable and permanent effects compared to OROS-MPH.
Keywords/Search Tags:Attention deficit disorder with hyperactivity, Methylphenidate, Delayed-action Preparations, Electroencephalography, biofeedback, Child
PDF Full Text Request
Related items
Study On The Changes Of Resting State FMRI After Discontinuation Of Medication In Children With Attention Deficit Hyperactivity Disorder Who Is Systemically Treated And Respond To Methylphenidate
Analysis Of Gut Microbiota Characteristics And Drug Therapy Associations In Children With Attention-deficit Hyperactivity Disorder
The Association Studies Of Sixteen Single Nucleotide Polymorphisms With Five Methylphenidate-induced Side Effects In Attention Deficit Hyperactivity Disorder
Study On EEG Characteristics And EEG Biofeedback Curative Effect In Attention Deficit/Hyperactivity Disorder Children
The Effects Of Methylphenidate And Atomoxetine On Physical Growth Indexes Of School-aged Children And Adolescents With Attention Deficit/Hyperactivity Disorder
Effects Of Methylphenidate On Cognitive Function In Children With Attention Deficit Hyperactivity Disorder: An Event-related Potentials Study
Population Pharmacokinetics Of Methylphenidate Hydrochloride Prolonged-Release Tablets And Relationship Between Plasma Concentration And Curative Effect In Patients With Attention Deficit/Hyperactivity Disorder
Study On Associations Of Phthalates Exposure,Neurotransmitter Pathway Gene Polymorphisms And Their Interaction With Child Attention Deficit-hyperactivity Disorder
An Event-Related Potentials Study For Chinese Characters Cognition In Attention Deficit Hyperactivity Disorder Children
10 Usefulness of parent-child observation in assessment for attention deficit/hyperactivity disorder among children